Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

ro,

Inc. (13,327) 810 (12,517)

Loss attributed to

non-controlling interest in

Symphony Allegro, Inc. 1,720 - 1,720

Net loss $(11,607) $810 $(10,797)

Basic and diluted net loss per

share $(0.49)

Shares used to compute basic

and diluted net loss per share 23,752

[1] Reflects operating results in accordance with U.S. generally accepted

accounting principles (or GAAP).

[2] Represents share-based compensation expense.

[3] Non-GAAP amounts exclude share-based compensation expense.

Alexza Pharmaceuticals, Inc.

(a development stage company)

Condensed Consolidated Statements of Operations

(in thousands except per share data)

Year Ended

December 31, 2007

GAAP [1] Difference [2] Non-GAAP [3]

Revenue $- $- $-

Operating expenses

Research and development 45,645 (1,885) 43,760

General and administrative 14,888 (1,531) 13,357

Total operating expenses 60,533 (3,416) 57,117

Loss from operations (60,533) 3,416 (57,117)

Interest and other income, net 5,626 - 5,626

Interest expense (1,003) - (1,003)

Loss before non-controlling

interest in Symphony Allegro,

Inc. (55,910) 3,416 (52,494)

Loss attributed to

non-controlling interest in

Symphony Allegro, I
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Alemania, 6 de marzo de 2015 ... de gestión empresarial de imagen médica, fortalece su ... nombramiento de Randolph Sternberg como director ... como director de operaciones. Logo - ... será responsable de las ventas y desarrollo ...
(Date:3/6/2015)... , March 6, 2015 Lucerne ... Trademark Office,s publication of U.S. Patent Application No. ... ,249 Patent Application features claimed methods of "informing ... used to treat Binge Eating Disorder (,BED,)," including ... or "flyer or an advertisement," as well as ...
(Date:3/6/2015)... -- UNICANCER pourra identifier plus ... de l,innovation thérapeutique.   TEMIS ... pour l,Entreprise, annonce que sa solution Luxid® a ... lutte contre le cancer (CLCC), comme module sémantique ... Soin-Recherche) conduit par la société de conseil et ...
Breaking Medicine Technology:TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4
... Jan. 20, 2011 TheCarrot.com , a ... engagement programs, announced the immediate availability of its ... of the University of California at San Francisco,s ... proven behavior modification methodology with TheCarrot.com,s award-winning online ...
... SYK ) announced today that it has been named ... in the magazine,s 14th annual survey of top-rated workplaces in the ... the list, and the company was ranked 68th out of 100; ... related stories will appear in the February 7 issue of FORTUNE, ...
Cached Medicine Technology:TheCarrot.com Launches Quit Smoking Program 2TheCarrot.com Launches Quit Smoking Program 3Stryker Corporation Named One of FORTUNE Magazine's '100 Best Companies to Work For' 2
(Date:3/6/2015)... NY (PRWEB) March 06, 2015 Based ... an estimated 52.5 million (22.7%) of adults have self-reported, ... well. Topical BioMedics now offers help to those ... initiative, whereby customers will receive 30% off their purchase ... free ¾ oz. tube of Topricin, plus a tube ...
(Date:3/6/2015)... NY (PRWEB) March 06, 2015 Dr. Amy ... been seeking a ban on the use of power morcellators ... recurrence of the cancer that prompted the launch of their ... earlier this week that the 41-year-old mother of six had ... bony part in her spine. Dr. Reed had been in ...
(Date:3/6/2015)... 2015 Ticket Down is a reliable source ... in Santa Clara, California. This state-of-the-art stadium opened on ... of exciting events. , The “Kick the Dust Up Tour” ... tour to the west coast and Levi’s Stadium. The show ... place on August 29 and fans of the award-winning artist ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... is one of the most common forms of cancer ... worldwide. Breast cancer can be screened through various techniques ... others. Mammography however remains the gold standard technique in ... such as cost, time taken for the procedure, required ...
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... their customer appreciation discount code ED-SHEERAN-2015 for added savings. , ... he began his career in the music industry 10 years ... Ed Sheeran has become a household name. , It ... is having the time of his life and his audiences ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 2Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 3Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 4Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 5Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 3Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 4Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 2Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 3Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2
... may want to talk to their doctors about whether to stay ... provides strong evidence that the use of HRT is associated with ... puts women at a great risk. The study also reports an ... HRT compared to those who have not. ,Between 20 percent ...
... drugs do prevent the onset of Parkinson’s disease. The study, ... anti-inflammatory drugs (NSAIDs) had a lower risk of Parkinson’s than ... is characterized by the death of neurons in the brain. ... appear to be protective in animal studies and they also ...
... who take certain types of painkillers, including aspirin, are ... said on Friday. But Paracetomol is not a risk, ... they added. ,Researchers in California interviewed more than 1,000 ... about their reproductive history and their use of painkillers. ...
... long and how well children survive cancer. ,The first ... chemotherapy but not radiation to the brain area tended ... life than those who got both treatments. But the ... study found the risk of hospitalization for psychiatric disorders ...
... has been shown to boost vitamin D levels and ... of disease. Higher sun exposure during childhood and early ... sclerosis, according to the study. ,Australian investigators conducted a ... and has a high prevalence of multiple sclerosis. //Researchers ...
... helps brain cells function normally also protects against Alzheimer's, ... to better treatments for the illness. ,Brain cells ... researchers in the United States, who identified it in ... protein in the brain which are a characteristic sign ...
Cached Medicine News:
... FingerPrint Sleep Hand-Held Pulse Oximeter with ... for sleep screening studies in the ... With its easy-to-use, 2-key operation, ... measurements of SpO 2 , pulse ...
... The BCI 3180 Pulse Oximeter is a ... SpO 2 pulse rate and pulse ... adult. This AC or battery powered ... low alarm limits and up to 30 ...
... Administration (FDA) has granted approval of Alcon's ... patients with and without presbyopia. This innovative ... to give patients a full range of ... greatly increases their independence from glasses after ...
Engineered for high volume surgical efficiencies, the Bausch & Lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-fre...
Medicine Products: